Michail Brovko

Clinical characteristics of 1007 intensive care unitpatients with SARS-CoV-2 pneumonia

Petr Glybochko, Sergey Moiseev, Andrey Yavorovskiy et al. · Clinical pharmacology and therapy · 2020 · 54 citations · Full text

Critical Care Medicine, Respiratory Diseases, Acute Care +5

Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial

Sergey Moiseev, Michail Brovko, Roman Maslennikov et al. · Probiotics and Antimicrobial Proteins · 2021 · 53 citations · Full text

Probiotic, Microbial Disease, Antibiotics +11

Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia

Petr Glybochko, Sergey Moiseev, Andrey Yavorovskiy et al. · Clinical pharmacology and therapy · 2020 · 30 citations · Full text

Covid-19 Epidemiology, Covid-19, Hospital Medicine +23

In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study

Mario Luca Morieri, Claudio Ronco, Angelo Avogaro et al. · Scientific Reports · 2022 · 16 citations · Full text

Efficacy of tocilizumab in the intensive care unit patients with COVID-19: a retrospective cohort study

Sergey Moiseev, E. Tao, Michail Brovko et al. · Clinical pharmacology and therapy · 2020 · 15 citations · Full text

Critical Care Management, Critical Care Medicine, Retrospective Cohort Study +11